Five things to know:
- In the first study, researchers analyzed 1.2 million EHR notes and more than 130,000 patients within the Mayo system. They compared post-vaccination follow-ups of 51,795 patients who received the Pfizer vaccine, 16,471 patients who received the Moderna vaccine and 68,266 who did not get vaccinated.
- The study found vaccinated patients were likely to experience muscle and joint soreness, myalgia, headache and fatigue, but were not more likely than unvaccinated patients to seek out emergency care.
- Severe events include anaphylaxis, facial paralysis and cerebral venous sinus thrombosis. These events were rare and occurred at similar rates in vaccinated and unvaccinated individuals, the study said.
- In the second study, the researchers analyzed the effectiveness of the Moderna and Pfizer vaccines. They analyzed rates of positive COVID-19 test results, hospitalization and ICU admission.
- The study found Pfizer is 86 percent effective against COVID-19 and Moderna is 93 percent effective. Both vaccines were 100 percent effective in preventing COVID-19-related ICU admissions.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
